37 min

Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama Squawk Pod

    • Investing

Pfizer CEO Albert Bourla says the company will have an omicron vaccine ready by March, just in case. He discusses global vaccine distribution, the covid treatment pill, and what he’s hoping for in 2022 with CNBC’s Meg Tirrell, Becky Quick, and Andrew Ross Sorkin. SEC Chairman Gary Gensler discusses regulatory goals on his 2022 docket, including bolstering transparency for investors. Plus, China is attempting to mitigate a surge of Omicron before the Winter Olympics, and tennis champion Novak Djokovic’s Aussie drama continues, courtside.

In this episode:
Gary Gensler, @GaryGensler
Albert Bourla, @AlbertBourla
Meg Tirrell, @megtirrell
Becky Quick, @BeckyQuick
Andrew Ross Sorkin, @andrewrsorkin
Cameron Costa, @CameronCostaNY

Pfizer CEO Albert Bourla says the company will have an omicron vaccine ready by March, just in case. He discusses global vaccine distribution, the covid treatment pill, and what he’s hoping for in 2022 with CNBC’s Meg Tirrell, Becky Quick, and Andrew Ross Sorkin. SEC Chairman Gary Gensler discusses regulatory goals on his 2022 docket, including bolstering transparency for investors. Plus, China is attempting to mitigate a surge of Omicron before the Winter Olympics, and tennis champion Novak Djokovic’s Aussie drama continues, courtside.

In this episode:
Gary Gensler, @GaryGensler
Albert Bourla, @AlbertBourla
Meg Tirrell, @megtirrell
Becky Quick, @BeckyQuick
Andrew Ross Sorkin, @andrewrsorkin
Cameron Costa, @CameronCostaNY

37 min

More by CNBC

CNBC
CNBC
CNBC
CNBC
CNBC
CNBC